Eli Lilly and Co (NYSE:LLY)

139.58
Delayed Data
As of Jan 17
 -1.85 / -1.31%
Today’s Change
101.36
Today|||52-Week Range
141.97
+6.20%
Year-to-Date
Eli Lilly's Shopping Spree Won't Stop With Dermira, CFO Shares Plans For More Deals In 2020
Jan 17 / MotleyFool.com - Paid Partner Content
Why AbbVie Could Be a Great Buy in 2020
Jan 13 / MotleyFool.com - Paid Partner Content
Incyte Stock Is Down: Buy the Dip?
Jan 15 / MotleyFool.com - Paid Partner Content
All the 2020 Pre-JPM News Healthcare Investors Need to Know
Jan 11 / MotleyFool.com - Paid Partner Content
Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products
Jan 14 / MotleyFool.com - Paid Partner Content
Eli Lilly to Boost Its Dermatology Pipeline with $1.1 Billion Dermira Acquisition
Jan 10 / MotleyFool.com - Paid Partner Content
Will Theravance Biopharma Finally Break Out in 2020?
Jan 14 / MotleyFool.com - Paid Partner Content
FibroGen Appoints Enrique Conterno as Its New CEO
Jan 06 / MotleyFool.com - Paid Partner Content